Literature DB >> 24229475

Dietary and lifestyle characteristics associated with normal-weight obesity: the National FINRISK 2007 Study.

Satu Männistö1, Kennet Harald1, Jukka Kontto1, Marjaana Lahti-Koski2, Niina E Kaartinen1, Suoma E Saarni1, Noora Kanerva1, Pekka Jousilahti1.   

Abstract

The aim of the present study was to compare the lifestyle (leisure-time physical activity, smoking habits and alcohol consumption) and dietary (energy-yielding nutrients, dietary fibre and foods) factors of Finns with a new syndrome called normal-weight obesity (NWO) with those of lean and overweight Finns. The representative population-based study included 4786 participants (25-74 years) from the National FINRISK 2007 Study with a health examination and questionnaires. Food intake was assessed using a validated FFQ. NWO was defined to include those with a normal BMI (<25 kg/m²) but excessive body fat (for men ≥20 % and for women ≥30 %) according to WHO definitions. The proportion of participants with a normal BMI was 28 % in men and 42 % in women. Of these, 34 % of the men and 45 % of the women had the NWO syndrome (among all the participants, 10 and 19 %, respectively). The waist circumference of the NWO participants was between that of the lean and overweight participants. Some potential risk factors, such as physical inactivity, (ex)-smoking and alcohol consumption, were related to NWO. In general, the intakes of energy-yielding nutrients were not associated with NWO. Instead, some healthy dietary factors (e.g. low intakes of meat and soft drinks) as well as unhealthy factors (e.g. low intakes of root vegetables, cereals and fish and high intake of confectionery) were related to NWO. The findings might explain why the NWO participants were of normal weight, but had an excessive body fat percentage. In conclusion, the proportion of normal-weight participants with an excessive body fat percentage was surprisingly high. The identification of NWO people may be of importance because although they appear lean, they have some unhealthy lifestyle and dietary habits related to obesity and overall health.

Entities:  

Mesh:

Year:  2013        PMID: 24229475     DOI: 10.1017/S0007114513002742

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  15 in total

1.  Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.

Authors:  Elina Isokuortti; You Zhou; Markku Peltonen; Elisabetta Bugianesi; Karine Clement; Dominique Bonnefont-Rousselot; Jean-Marc Lacorte; Amalia Gastaldelli; Detlef Schuppan; Jörn M Schattenberg; Antti Hakkarainen; Nina Lundbom; Pekka Jousilahti; Satu Männistö; Sirkka Keinänen-Kiukaanniemi; Juha Saltevo; Quentin M Anstee; Hannele Yki-Järvinen
Journal:  Diabetologia       Date:  2017-06-29       Impact factor: 10.122

Review 2.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

3.  Physical Fitness but Not Diet Quality Distinguishes Lean and Normal Weight Obese Adults.

Authors:  Moriah P Bellissimo; Erika L Bettermann; Phong H Tran; Benjamin H Crain; Erin P Ferranti; Jose N Binongo; Terryl J Hartman; Dean P Jones; Thomas R Ziegler; Jessica A Alvarez
Journal:  J Acad Nutr Diet       Date:  2020-10-01       Impact factor: 4.910

Review 4.  Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review.

Authors:  Nadeeja Niranjalie Wijayatunga; Emily Jane Dhurandhar
Journal:  Int J Obes (Lond)       Date:  2021-05-18       Impact factor: 5.095

5.  Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort.

Authors:  Dagrun Engeset; Tonje Braaten; Birgit Teucher; Tilman Kühn; H B Bueno-de-Mesquita; Max Leenders; Antonio Agudo; Manuela M Bergmann; Elisavet Valanou; Androniki Naska; Antonia Trichopoulou; Timothy J Key; Francesca L Crowe; Kim Overvad; Emily Sonestedt; Amalia Mattiello; Petra H Peeters; Maria Wennberg; Jan Håkan Jansson; Marie-Christine Boutron-Ruault; Laure Dossus; Laureen Dartois; Kuanrong Li; Aurelio Barricarte; Heather Ward; Elio Riboli; Claudia Agnoli; José María Huerta; María-José Sánchez; Rosario Tumino; Jone M Altzibar; Paolo Vineis; Giovanna Masala; Pietro Ferrari; David C Muller; Mattias Johansson; M Luisa Redondo; Anne Tjønneland; Anja Olsen; Karina Standahl Olsen; Magritt Brustad; Guri Skeie; Eiliv Lund
Journal:  Eur J Epidemiol       Date:  2014-11-07       Impact factor: 8.082

6.  Normal weight adiposity in a Swedish population: how well is cardiovascular risk associated with excess body fat captured by BMI?

Authors:  Christina Berg; Elisabeth Strandhagen; Kirsten Mehlig; Sreevidya Subramoney; Lauren Lissner; Lena Björck
Journal:  Obes Sci Pract       Date:  2015-09-15

7.  Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?

Authors:  Onni Niemelä; Markus Niemelä; Risto Bloigu; Mauri Aalto; Tiina Laatikainen
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

8.  Characteristics of Physical Fitness and Cardiometabolic Risk in Chinese University Students with Normal-Weight Obesity: A Cross-Sectional Study.

Authors:  Qianqian Tian; Hui Wang; Keneilwe Kenny Kaudimba; Shanshan Guo; Haixin Zhang; Song Gao; Ruwen Wang; Xin Luan; Jason Kai Wei Lee; Peijie Chen; Tiemin Liu; Ru Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-04       Impact factor: 3.168

9.  Characteristics of Body Composition and Lifestyle in Chinese University Students with Normal-Weight Obesity: A Cross-Sectional Study.

Authors:  Gusonghan Maitiniyazi; Yue Chen; Yu-Yu Qiu; Zhen-Xing Xie; Jian-Yun He; Shu-Fang Xia
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-28       Impact factor: 3.168

10.  Health Behavior and Metabolic Risk Factors Associated with Normal Weight Obesity in Adolescents.

Authors:  Anna S Olafsdottir; Johanna E Torfadottir; Sigurbjorn A Arngrimsson
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.